InStyle: Top 50 health care workers who are saving the day
UC Cancer Center expert represents Ohio in article about researchers making an impact
Trisha Wise-Draper, MD, PhD, is an associate professor at the UC College of Medicine and was recently named one of "The Badass 50" by InStyle Magazine for her work during the COVID-19 pandemic. Photo/Colleen Kelley/UC Creative + Brand
Eighteen-hour shifts. End-of-life care. Lack of proper equipment. Frontline health care workers have been facing seemingly insurmountable challenges during the COVID-19 pandemic.
And yet, they get the job done.
InStyle Magazine went state by state to celebrate these heroes. Trisha Wise-Draper, MD, PhD, associate professor in the Division of Hematology Oncology at UC, a UC Health oncologist and medical director of the UC Cancer Center's Clinical Trials Office, represented Ohio and discussed her contributions during this difficult time.
"Cancer never stops, whether there is a pandemic or not, making my position more critical than ever," she says.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.